For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221202:nRSB4900Ia&default-theme=true
RNS Number : 4900I Kanabo Group PLC 02 December 2022
Kanabo Group Plc.
("Kanabo" or the "Company")
Resignation of Auditor
Kanabo Group plc (LSE:KNB) the pan-European medical cannabis company that
focuses on developing and commercialising cannabis-derived products for
medical patients and wellness consumers, announces Jeffreys Henry LLP
('Jeffreys Henry') has resigned as the Company's independent auditor with
immediate effect on the grounds that Jeffrey's Henry has taken the decision
not to register itself with the Financial Reporting Council as an eligible
auditor to undertake Public Interest Entity audits.
In accordance with s. 519 Companies Act 2006, Jeffreys Henry made the
following statements:
· We [Jeffreys Henry] have resigned as auditor with immediate effect on
the grounds that the firm has taken the decision not to register as an auditor
eligible to undertake Public Interest Entity audits.
· There are no circumstances connected with our ceasing to hold office
as auditor which we [Jeffreys Henry] consider should be brought to the
attention of the company's members or creditors.
The process to appoint a new independent auditor for the Company is well
advanced and further announcements will be made in due course.
For further information, please visit http://www.kanabogroup.com/ or
https://www.voxmarkets.co.uk/listings/LON/KNB
(https://www.voxmarkets.co.uk/listings/LON/KNB) or contact the following:
Kanabo Group Plc Via Vox Markets
Avihu Tamir, CEO
Peterhouse Capital Ltd (Financial Adviser) Tel: +44 (0)20 7469 0930
Eran Zucker
Peterhouse Capital Ltd (Corporate Broker)
Lucy Williams / Charles Goodfellow
Vox Markets Ltd (Investor Relations) KanaboGroup@voxmarkets.co.uk
Kat Perez kperez@voxmarkets.co.uk
RKM Communications Ltd (Media Relations)
Nic Barnes nic.barnes@rkmcom.com
About Kanabo Group Plc
Kanabo Group Plc, is a leading developer and distributer of cannabis-derived
products and inhalation technologies for medical patients and non-THC products
for CBD consumers. Kanabo Group Plc was the first medicinal cannabis company
to IPO on London Stock Exchange and is made up of supply-chain specialist
subsidiaries, from cultivation consultancy to R&D to formula development
and distribution, including:
· Kanabo Agritec Ltd, a cultivation consultancy supporting cannabis
businesses in developing new farms through infrastructural, research, and
product guidance. These farms deliver high-quality raw materials for Kanabo's
formulas and product line.
· Kanabo Research Ltd, a wholly owned subsidiary of Kanabo Group Plc,
responsible for R&D, regulation, and quality assurance procedures.
· The GP Service - a Kanabo Group Plc owned telehealth provider,
offering NHS approved online consultations, online prescriptions, treatment
forms and access to both Kanabo medical-cannabis & wellbeing CBD products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END APPUPGAAPUPPGCP